Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 53, 1059-1063, March 1, 1993]
© 1993 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tennent, B. J.
Right arrow Articles by Beamer, W. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tennent, B. J.
Right arrow Articles by Beamer, W. G.

Genetic Susceptibility for C19 Androgen Induction of Ovarian Granulosa Cell Tumorigenesis in SWXJ Strains of Mice1

Barbara J. Tennent2, Kathryn L. Shultz and Wesley G. Beamer

The Jackson Laboratory, Bar Harbor, Maine 04609

Susceptibility to pubertal onset, malignant granulosa cell (GC) tumors of the ovary is inherited in SWR/Bm and certain SWR-related SWXJ recombinant inbred strains of mice. In some SWXJ strains, GC tumors occur spontaneously (spontaneous strains), and in others GC tumors can only be induced by treatment with dehydroepiandrosterone (DHEA-dependent strains). A gene controlling susceptibility to both spontaneous and DHEA-induced GC tumorigenesis, Gct, has been assigned to Chromosome 4.

Additional research on the role of steroids in GC tumorigenesis has revealed a second gene controlling response to C19 androgenic steroids. Spontaneous strains showed increased tumor frequency after treatment with testosterone (T), whereas DHEA-dependent strains showed no GC tumors following T treatment. Within treatment groups, serum steroid data from DHEA, T, and control treated mice showed no consistent differences between spontaneous and DHEA-dependent strains with respect to progesterone, DHEA, androstenedione, dihydrotestosterone, T, estrone, or estradiol. Thus, observed differences in GC tumor responsiveness to exogenous steroids were not due to different patterns of steroid metabolism among spontaneous and DHEA-dependent strains.

Further studies on the range of effective C19 steroids were conducted using one spontaneous and one DHEA-dependent strain. The spontaneous strain showed increased GC tumor frequency in response to dihydrotestosterone and androsterone treatment, whereas the DHEA-dependent strain showed no response. This result suggests that spontaneous strains may be sensitive to a broad range of C19 steroids.

To determine whether genetic differences in endogenous steroid levels have a role in spontaneous GC tumorigenesis, serum steroid levels were measured in SWR/Bm and SJL/Bm progenitor strains during the developmental period of risk between 22 and 38 days of age. With the exception of transiently increased DHEA at 22 days, there were no consistent differences in steroid levels analyzed. Thus, serum steroid profiles were not reliably prognostic for GC tumorigenesis.

In conclusion, GC tumor induction in response to T treatment has co-segregated with susceptibility to spontaneous GC tumors in the SWXJ recombinant inbred strains. Thus, the second gene in our ovarian granulosa cell tumor model regulates responsiveness to T. We propose to name this gene spontaneous ovarian tumorigenesis (Sot), with alleles for susceptibility (s) carried by spontaneous strains and resistance (r) carried by DHEA-dependent strains.

1 This work supported by National Cancer Institute Grant CA-42363, American Cancer Society Grant CD-265, and Jackson Laboratory Institutional Cancer CORE CA-34196. The Jackson Laboratory is fully accredited by the American Association for Accreditation of Laboratory Animal Care.

2 To whom requests for reprints should be addressed, at The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609.

Received 8/27/92. Accepted 12/18/92.




This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
A. M Dorward, K. L Shultz, and W. G Beamer
LH analog and dietary isoflavones support ovarian granulosa cell tumor development in a spontaneous mouse model
Endocr. Relat. Cancer, June 1, 2007; 14(2): 369 - 379.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Rinaldi, L. Dossus, A. Lukanova, P. H.M. Peeters, N. E. Allen, T. Key, S. Bingham, K.-T. Khaw, D. Trichopoulos, A. Trichopoulou, et al.
Endogenous Androgens and Risk of Epithelial Ovarian Cancer: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC)
Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 23 - 29.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. M. Dorward, K. L. Shultz, L. G. Horton, R. Li, G. A. Churchill, and W. G. Beamer
Distal Chr 4 Harbors a Genetic Locus (Gct1) Fundamental for Spontaneous Ovarian Granulosa Cell Tumorigenesis in a Mouse Model
Cancer Res., February 15, 2005; 65(4): 1259 - 1264.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. D. Fillmore, E. P. Blankenhorn, J. F. Zachary, and C. Teuscher
Adult Gonadal Hormones Selectively Regulate Sexually Dimorphic Quantitative Traits Observed in Experimental Allergic Encephalomyelitis
Am. J. Pathol., January 1, 2004; 164(1): 167 - 175.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. M. Dorward, K. L. Shultz, C. L. Ackert-Bicknell, E. M. Eicher, and W. G. Beamer
High-Resolution Genetic Map of X-Linked Juvenile-Type Granulosa Cell Tumor Susceptibility Genes in Mouse
Cancer Res., December 1, 2003; 63(23): 8197 - 8202.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
K. H. Burns, J. E. Agno, L. Chen, B. Haupt, S. C. Ogbonna, K. S. Korach, and M. M. Matzuk
Sexually Dimorphic Roles of Steroid Hormone Receptor Signaling in Gonadal Tumorigenesis
Mol. Endocrinol., October 1, 2003; 17(10): 2039 - 2052.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. A. Keri, K. L. Lozada, F. W. Abdul-Karim, J. H. Nadeau, and J. H. Nilson
Luteinizing hormone induction of ovarian tumors: Oligogenic differences between mouse strains dictates tumor disposition
PNAS, January 4, 2000; 97(1): 383 - 387.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
W. Shou, T. K. Woodruff, and M. M. Matzuk
Role of Androgens in Testicular Tumor Development in Inhibin-Deficient Mice
Endocrinology, November 1, 1997; 138(11): 5000 - 5005.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. Amsterdam and N. Selvaraj
Control of Differentiation, Transformation, and Apoptosis in Granulosa Cells by Oncogenes, Oncoviruses, and Tumor Suppressor Genes
Endocr. Rev., August 1, 1997; 18(4): 435 - 461.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1993 by the American Association for Cancer Research.